Clinical and Preclinical Results for Acetylon Pharmaceuticals’ ACY-1215 for the Treatment of Multiple Myeloma Presented at the 54th Annual Meeting of the American Society of Hematology
Other Sources for this Article
Acetylon Pharmaceuticals Inc.
Walter C. Ogier, 617-245-1300
President and Chief Executive Officer
MacDougall Biomedical Communications
Kari Watson, 781-235-3060
Michelle Avery, 781-235-3060